A new compound that blocks an early step in cell death could lead to a novel class of drugs for treating heart attacks and stroke.
When cells are deprived of oxygen -- during a heart attack, for example -- they start to die through a tidy process called apoptosis or programmed cell death. Early in apoptosis, the mitochondria -- complex structures that supply energy to the cell -- divide into pieces, holes appear in their membranes and proteins such as cytochrome c leak out. These events trigger other processes, ending in cell death.
"Mitochondria divide like crazy during apoptosis," said Jodi Nunnari, professor of molecular and cellular biology at UC Davis and senior author on the paper. Nunnari's lab has been studying the fundamental processes of mitochondrial division for several years.
The researchers screened 23,000 compounds to find those that blocked mitochondrial division in yeast cells. From three "hits" they picked the most effective, named mdivi-1.
They found that mdivi-1 blocks mitochondrial division dynamin, one of a class of proteins found in both yeast and mammals that can assemble itself into a spiral garrotte around the mitochondrion and cut it in two. Mdivi-1 interfered with the self-assembly of dynamin in both yeast and mammalian cells.
Mdivi-1 also blocked the process that punches holes in the mitochondrial membrane, preventing leakage of cytochrome c. The researchers found that this process could also be traced back to the effect of mdivi-1 on dynamin.
Dynamins could be a target for drugs that prevent cells from dying -- during strokes, for example, or during heart attacks or in diseases where nerve cells progressively deteriorate and die, Nunnari said. She also noted that the work would not have been possible without having first gained a fundamental understanding of how mitochondrial division works.
Source: University of California - Davis
Related stories:
Common bacteria activating natural killer T cells may cause autoimmune liver disease
A bacteria commonly found in soil and water triggered autoimmune symptoms in mice similar to those found in an incurable liver disease called Primary Biliary Cirrhosis (PBC). Reporting their findings in the May 15
Cell Host & Microbe, the multi-institutional research team said injecting laboratory mice with the bacterium – Novosphingobium aromaticivorans – prompted activation of Natural Killer T (NKT) cells, which were critical to initiating autoimmune processes that led to liver disease.
Yeast gives rise to new concept: cell fuel is 'brains' behind division
With the cost of diesel and gasoline getting nearer to the hourly minimum wage, too bad the fuel doesn’t do more work - like deciding what route to take and pressing the gas pedal.
Investigational drug tested for preventing muscle fiber death in muscular dystrophy
An investigational antiviral drug currently undergoing human trials in Europe for treating Hepatitis C infections may have potential to reduce muscle cell damage in Duchenne and other forms of muscular dystrophy (MD). A research team led by Cincinnati Children’s Hospital Medical Center reported their results using three different mouse models of MD in a letter posted online March 16 by the journal
Nature Medicine.
Could hydrogen sulfide hold the key to a long life?
Hydrogen sulfide, or H2S, the chemical that gives rotten eggs their sulfurous stench – and the same compound that researchers at Fred Hutchinson Cancer Research Center successfully have used to put mice into a state of reversible metabolic hibernation – has now been shown to significantly increase life span and heat tolerance in the nematode worm, or C. elegans.
Mitochondria send death signal to cardiac cells, study shows
Scientists have determined how cardiac cells die just as emergency treatments restore blood flow to a heart in distress, a paradox that has long puzzled doctors who are able to relieve pain in patients suffering from blocked arteries but can't stop the damage caused by the renewed rush of blood.
Worm study sheds light on human aging, inherited diseases
Microscopic worms used for scientific research are living longer despite cellular defects, a discovery that is shedding light on how the human body ages and how doctors could one day limit or reverse genetic mutations that cause inherited diseases, according to a new University of Colorado at Boulder study.
Researchers identify a role for glucose-sensing neurons in type 2 diabetes
In cases of Type 2 diabetes, the body’s cells fail to appropriately regulate blood glucose levels. Research has suggested that this results from two simultaneous problems: the improper functioning of pancreatic beta cells and the impairment of insulin’s actions on target tissues, including the liver, fat and muscles.
New use for a cell toxin found to inhibit survival proteins in cancer cells
A chemically-modified version of a mitochondrial toxin long used to control species of invasive fish in lakes has been found to selectively inhibit two "survival proteins” in cancer cells. The research is a first step toward developing a molecularly-targeted drug that could eliminate cellular-level resistance to multiple types of chemotherapy and radiation therapy found in many types of cancers.